These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29621786)

  • 1. Relationship between the von Willebrand Factor Plasma Concentration and Ultrasonographic Doppler Findings in Pregnancies Complicated by Hypertensive Disorders: A Pilot Study.
    Szpera-Gozdziewicz A; Gozdziewicz T; Boruczkowski M; Dworacki G; Breborowicz GH
    Gynecol Obstet Invest; 2018; 83(3):252-258. PubMed ID: 29621786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial cells, circulating endothelial progenitor cells, and von Willebrand factor in pregnancies complicated by hypertensive disorders.
    Szpera-Goździewicz A; Majcherek M; Boruczkowski M; Goździewicz T; Dworacki G; Wicherek L; Bręborowicz GH
    Am J Reprod Immunol; 2017 Mar; 77(3):. PubMed ID: 28224722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
    Florio P; Torricelli M; De Falco G; Leucci E; Giovannelli A; Gazzolo D; Severi FM; Bagnoli F; Leoncini L; Linton EA; Petraglia F
    J Hypertens; 2006 Sep; 24(9):1831-40. PubMed ID: 16915033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia.
    Cadroy Y; Grandjean H; Pichon J; Desprats R; Berrebi A; Fournié A; Boneu B
    Br J Obstet Gynaecol; 1993 May; 100(5):416-20. PubMed ID: 8518239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma osteopontin concentrations in preeclampsia - is there an association with endothelial injury?
    Stenczer B; Rigó J; Prohászka Z; Derzsy Z; Lázár L; Makó V; Cervenak L; Balogh K; Mézes M; Karádi I; Molvarec A
    Clin Chem Lab Med; 2010 Feb; 48(2):181-7. PubMed ID: 19943814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of placental vascularization by three-dimensional ultrasound examination in second and third trimester of pregnancies complicated by chronic hypertension, gestational hypertension or pre-eclampsia.
    Surányi A; Altorjay Á; Kaiser L; Nyári T; Németh G
    Pregnancy Hypertens; 2017 Apr; 8():51-59. PubMed ID: 28501280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia.
    Deng L; Bremme K; Hansson LO; Blombäck M
    Obstet Gynecol; 1994 Dec; 84(6):941-5. PubMed ID: 7970473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
    Nadar SK; Al Yemeni E; Blann AD; Lip GY
    Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal hypertension is associated with an exacerbation of the endothelial damage in preeclampsia.
    Bouchlariotou S; Liakopoulos V; Dovas S; Giannopoulou M; Kiropoulos T; Zarogiannis S; Gatselos G; Zachopoulos T; Kyriakou DS; Kallitsaris A; Messinis I; Stefanidis I
    Am J Nephrol; 2008; 28(3):424-30. PubMed ID: 18097134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of plasma Von Willebrand factor and Von Willebrand factor-cleaving protease levels in pregnancy-induced hypertension.
    Zhang TT; Yu ZK; Xiu CF; Bai YT; Peng M; Guo ZH
    J Biol Regul Homeost Agents; 2020; 34(3):1147-1152. PubMed ID: 32608221
    [No Abstract]   [Full Text] [Related]  

  • 13. Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology.
    Stepanian A; Cohen-Moatti M; Sanglier T; Legendre P; Ameziane N; Tsatsaris V; Mandelbrot L; de Prost D; Veyradier A;
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1703-9. PubMed ID: 21512165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta.
    Parra-Cordero M; Bosco C; González J; Gutiérrez R; Barja P; Rodrigo R
    J Mol Histol; 2011 Oct; 42(5):459-65. PubMed ID: 21847508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor.
    Karthikeyan VJ; Blann AD; Baghdadi S; Lane DA; Gareth Beevers D; Lip GY
    Clin Res Cardiol; 2011 Jun; 100(6):531-7. PubMed ID: 21221608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of severe placental insufficiency and systemic venous pressure rise in the fetus with increased neonatal cardiac troponin T levels.
    Mäkikallio K; Vuolteenaho O; Jouppila P; Räsänen J
    Am J Obstet Gynecol; 2000 Sep; 183(3):726-31. PubMed ID: 10992200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.
    Verlohren S; Perschel FH; Thilaganathan B; Dröge LA; Henrich W; Busjahn A; Khalil A
    Hypertension; 2017 Jun; 69(6):1192-1197. PubMed ID: 28461601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal hemodynamics: a method to classify hypertensive disorders of pregnancy.
    Ferrazzi E; Stampalija T; Monasta L; Di Martino D; Vonck S; Gyselaers W
    Am J Obstet Gynecol; 2018 Jan; 218(1):124.e1-124.e11. PubMed ID: 29102503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in plasma von Willebrand factor and nitric oxide levels in patients with pregnancy induced hypertension].
    Jin LP; Wang CH; Chen JL
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):477-9. PubMed ID: 12536509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.